title: OCT-verified neointimal hyperplasia is increased at fracture site in drug-eluting stents.
authors.forename: Manabu
authors.initials: M
authors.lastname: Kashiwagi
authors.forename: Atsushi
authors.initials: A
authors.lastname: Tanaka
authors.forename: Hironori
authors.initials: H
authors.lastname: Kitabata
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Ino
authors.forename: Hiroto
authors.initials: H
authors.lastname: Tsujioka
authors.forename: Kenichi
authors.initials: K
authors.lastname: Komukai
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Ozaki
authors.forename: Kohei
authors.initials: K
authors.lastname: Ishibashi
authors.forename: Takashi
authors.initials: T
authors.lastname: Tanimoto
authors.forename: Shigeho
authors.initials: S
authors.lastname: Takarada
authors.forename: Takashi
authors.initials: T
authors.lastname: Kubo
authors.forename: Kumiko
authors.initials: K
authors.lastname: Hirata
authors.forename: Masato
authors.initials: M
authors.lastname: Mizukoshi
authors.forename: Toshio
authors.initials: T
authors.lastname: Imanishi
authors.forename: Takashi
authors.initials: T
authors.lastname: Akasaka
mesh_terms: D017023:Coronary Angiography; D003331:Coronary Vessels / Q000473:pathology*; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D004868:Equipment Failure; D006801:Humans; D006965:Hyperplasia; D058426:Neointima / Q000473:pathology*; D020123:Sirolimus; D041623:Tomography, Optical Coherence
chemical_list: D020123:Sirolimus